Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Changli Wei

Showing results (41-50 of 79) with videos related to

Pageof 8
Sort By:
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|August 21, 2018
Soluble urokinase-type plasminogen activator receptor and incident end-stage renal disease in Chinese patients with chronic kidney diseaseLi Lv, Fang Wang, Liang Wu, et al.
BMC Nephrology|July 23, 2015
Efficacy of galactose and adalimumab in patients with resistant focal segmental glomerulosclerosis: report of the font clinical trial groupHoward Trachtman, Suzanne Vento, Emily Herreshoff, et al.
Ebiomedicine|November 4, 2025
Soluble urokinase receptor is a kidney-specific vasoconstrictorSebastian Buhl Rasmussen, Rasmus Bo Lindhardt, Georgina Gyarmati, et al.
Kidney International Reports|November 17, 2017
Cardiovascular Disease Biomarkers and suPAR in Predicting Decline in Renal Function: A Prospective Cohort StudySalim S Hayek, Yi-An Ko, Mosaab Awad, et al.
Kidney International|August 1, 2012
Regarding Maas's editorial letter on serum suPAR levelsHoward Trachtman, Debbie S Gipson, Frederick Kaskel, et al.
Journal of Cardiac Failure|September 19, 2022
Soluble Urokinase Plasminogen Activator Receptor Levels and Outcomes in Patients with Heart FailureSalim S Hayek, Ayman Samman Tahhan, Yi-An Ko, et al.
Plos One|September 30, 2010
Podocyte-specific overexpression of wild type or mutant trpc6 in mice is sufficient to cause glomerular diseasePaola Krall, Cesar P Canales, Pamela Kairath, et al.
The Journal of Pathology|November 20, 2014
BDNF repairs podocyte damage by microRNA-mediated increase of actin polymerizationMin Li, Silvia Armelloni, Cristina Zennaro, et al.
Journal of the American Society of Nephrology : JASN|April 11, 2015
A Podocyte-Based Automated Screening Assay Identifies Protective Small MoleculesHa Won Lee, Samia Q Khan, Mohd Hafeez Faridi, et al.
Journal of the American Society of Nephrology : JASN|December 15, 2006
Induction of TRPC6 channel in acquired forms of proteinuric kidney diseaseClemens C Möller, Changli Wei, Mehmet M Altintas, et al.
Pageof 8

Showing results (41-50 of 79) with videos related to

Sort By:
Pageof 8
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|August 21, 2018
Soluble urokinase-type plasminogen activator receptor and incident end-stage renal disease in Chinese patients with chronic kidney diseaseLi Lv, Fang Wang, Liang Wu, et al.
BMC Nephrology|July 23, 2015
Efficacy of galactose and adalimumab in patients with resistant focal segmental glomerulosclerosis: report of the font clinical trial groupHoward Trachtman, Suzanne Vento, Emily Herreshoff, et al.
Ebiomedicine|November 4, 2025
Soluble urokinase receptor is a kidney-specific vasoconstrictorSebastian Buhl Rasmussen, Rasmus Bo Lindhardt, Georgina Gyarmati, et al.
Kidney International Reports|November 17, 2017
Cardiovascular Disease Biomarkers and suPAR in Predicting Decline in Renal Function: A Prospective Cohort StudySalim S Hayek, Yi-An Ko, Mosaab Awad, et al.
Kidney International|August 1, 2012
Regarding Maas's editorial letter on serum suPAR levelsHoward Trachtman, Debbie S Gipson, Frederick Kaskel, et al.
Journal of Cardiac Failure|September 19, 2022
Soluble Urokinase Plasminogen Activator Receptor Levels and Outcomes in Patients with Heart FailureSalim S Hayek, Ayman Samman Tahhan, Yi-An Ko, et al.
Plos One|September 30, 2010
Podocyte-specific overexpression of wild type or mutant trpc6 in mice is sufficient to cause glomerular diseasePaola Krall, Cesar P Canales, Pamela Kairath, et al.
The Journal of Pathology|November 20, 2014
BDNF repairs podocyte damage by microRNA-mediated increase of actin polymerizationMin Li, Silvia Armelloni, Cristina Zennaro, et al.
Journal of the American Society of Nephrology : JASN|April 11, 2015
A Podocyte-Based Automated Screening Assay Identifies Protective Small MoleculesHa Won Lee, Samia Q Khan, Mohd Hafeez Faridi, et al.
Journal of the American Society of Nephrology : JASN|December 15, 2006
Induction of TRPC6 channel in acquired forms of proteinuric kidney diseaseClemens C Möller, Changli Wei, Mehmet M Altintas, et al.
Pageof 8